Copy
Welcome to the Newsletter of the Organisation of European Cancer Institutes!

We aim in these Newsletters to keep you informed of the news and current affairs of the organisation, and to further involve our member centres in its growth and development. 

Registrations are now closed for the OECI Oncology Days, which will take place on 14 - 16 June, 2023 in Paris.

Scroll down to access the latest edition of the OECI Magazine N. 1 | June, 2023: "A Window on the past, a door to the OECI future".

Finally, read more on two EC Actions OECI is presently involved in - "Comprehensive Cancer Infrastructure 4 Europe" and "Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe".
Table of Contents
In the spotlight

Registrations closed | OECI Oncology Days 2023

Registrations for the 45th Edition of the OECI Oncology Days are now closed due to full capacity of the event venue.  We would like to thank the 350 participants who have registered and will be joining us in Paris on 14 - 16 June 2023

❗ If you are a delegate of an OECI Member, you may still register for the event in order to be able to participate in the OECI General Assembly by contacting oeci@oeci.eu

OECI Publications | OECI Magazine

The N.1 Edition of the OECI Magazine 2023 is now out!

The OECI Magazine is an inclusive communication tool designed to promote OECI’s mission.

Launched in December 2017, the Magazine is an independent source featuring news in the field of cancer; a glimpse behind OECI’s running activities, updates on the latest EC actions and additional topics of interest for the whole European cancer community.
 

Go to Magazine

EC Actions | Comprehensive Cancer Infrastructures 4 Europe (CCI4EU)

That's a wrap! It was great to bring together 55 beneficiaries from 27 EU Member States and 5 Associated Countries for the kick-off meeting of the Comprehensive Cancer Infrastructures 4 Europe CCI4EU Project, which took place in Milan, on 23 - 24 May, 2023.
This CSA aims at ➡
🎯Defining a Maturity Model based on cancer research/care performance indicators to be used to analyse the maturity of CCIs across the EU
🎯 Mapping the maturity of CCIs according to the agreed quality indicators and clustering them according to maturity
🎯Designing tailored capacity building  interventions, giving priority to EU countries without any CCI 
🎯Delivering online training courses open to all EU Member States and Associated Countries
🎯 Implementing  targeted onsite interventions 
🎯Scaling up and sustaining development by dynamically engaging the right stakeholders; disseminating and exploiting project outcomes
Funded by the European Union’s Research and Innovation Programme HORIZON-MISS-2022-CANCER-01 under grant agreement 101103746 Project CCI4EU.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.
Learn more

EC Actions | Quality of Life in Oncology: measuring what matters for cancer patients and survivors in Europe (EUonQoL)

A new barometer for the assessment of QoL of cancer patients and survivors in Europe

The EUonQoL project is a European multi-stakeholder consortium, involving research institutions, cancer centres, as well as scientific, professional, and patient representative organisations, all with extensive experience and robust scientific background in the development of self-report QoL measures. It aims to develop, pilot, and validate a patient-driven and unified system for assessment of QoL (EUonQoL toolkit) in cancer patients and survivors across Europe.

This fully digital toolkit will allow the collection of QoL reports from cancer patients and survivors across Europe to inform policy changes at the EU level. The development of the EUonQoL toolkit will take into account different cancer populations to ensure a better representation of patients and survivors who have experienced different types of cancer. 

Project leaders from Istituto Nazionale dei Tumori (Italy), Dr Cinzia Brunelli and Prof Giovanni Apolone, shared that: “The plan is for the EUonQoL toolkit to be used repeatedly throughout the years to monitor how various EU cancer programmes have contributed to the quality of life of cancer patients and survivors.

How?
👉  Existing QoL tools will be reviewed, scoping all relevant sources. 
👉 A multidisciplinary researcher panel, composed by the most talented experts, will develop the EUonQoL-Kit that will be validated in a pilot survey using digital data collection within month 24 of the project.
👉  A total of 4,000 cancer patients and survivors will be enrolled through a network of EU cancer centres in 27 EU MS, 6 Associate Countries and the UK. 
👉 An analysis of factors potentially impacting on cancer patients and survivors QoL, will also be performed. Implementation and exploitation strategies, as well as the linkage with other Cancer Mission actions will be explored to develop future periodic surveys.
Funded by the European Union’s Research and Innovation Programme HORIZON-MISS-2021-CANCER-02 under grant agreement 101096362 Project EUonQoL. 
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency (HADEA). Neither the European Union nor the granting authority can be held responsible for them.
Follow this project on LinkedIn Follow this project on LinkedIn
Follow this project on Twitter Follow this project on Twitter
Learn more

European Cancer Community | IPOS 2023 World Congress

OECI is delighted to endorse the 24th World Congress of Psycho-Oncology 2023, which will be held in Milano, Italy, from 31st August to 3rd September 2023.

The theme for the meeting is: Championing our Patients’ Future Through Collaboration and Innovation in Psycho-Oncology. Moreover, 5 goals have been defined: innovation, education, equity, measuring efficacy, and sustainable psychology.

This Symposium will focus on the innovative methodological approaches used to develop a European Oncology Quality of Life toolkit (EUonQoL-Kit) among European cancer patients and survivors. Moreover, this Symposium will present the gaps in the body of evidence and in currently available QoL assessment tools, thus showing the main steps to overcome barriers and implement a standard European QoL assessment system.

The first presentation will give an overview of the H2020 European “EUonQoL” Project focusing on its rational and main ambitions, and introducing the methodologies used for the development of the toolkit.

Secondly, patients’ and stakeholders’ practical involvement to address their preferences will be showed.

The third presentation will summarize the existing evidence on the topics and identify gaps based on patients and stakeholder needs.

The fourth presentation will show the development of a method to validate Quality of Life scales using social network posts.

Lastly, the identification of psychosocial determinants of QoL affecting cancer patients’ experience will be presented, thus allowing a more comprehensive vision of QoL aspects in Europe.

Learn more

European Cancer Community | IARC Summer School 2023

This year, the International Agency for Research on Cancer (IARC) is thrilled to unveil a brand-new line-up of live online events, to be held during the IARC Summer School and open to the public.

Online viewers will be able to be in the virtual classroom, with the selected participants, and attend selected sessions of the modules “Introduction to Cancer Epidemiology” (EPI) and “Implementing Cancer Prevention and Early Detection” (PREV). All sessions will start at 13:00 CEST enabling attendees to join from all around the world.

View the programme prepared by the IARC Course Directors and pick your session(s) in the registration form.
Register here

OECI is on Social Media

OECI is on social media! Don't forget to follow us on LinkedIn, Twitter and Facebook for our latest news and updates !
Facebook
Twitter
LinkedIn






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Organisation of European Cancer Institutes · Rue d'Egmont, 11 · BRUSSELS 1000 · Belgium